Metabiomics

Opioids can be effective for pain relief when used as prescribed, but they also carry the risk of dependence, misuse, and addiction, with factors like genetics playing a role. AvertD, an FDA-approved test, uses DNA from buccal swabs to determine whether they have a specific set of genetic variants that may be associated with an elevated genetic risk of developing opioid use disorder (OUD). AvertD can be a crucial part of assessing a patient’s risk for OUD within a comprehensive clinical evaluation.

Learn more about AvertD by SOLVD Health: https://avertdtest.com/

The majority of colon cancers can be prevented with screening programs that deploy colonoscopy and non-invasive tests. There's still a need for more sensitive stool tests, which is exactly what Metabiomics is focused on.

As many avoid colonoscopies, doctors say non-invasive tests could help prevent colorectal cancer Less may be more when it comes to colonoscopies. While it’s a highly effective screening tool, the invasive colonoscopy is uncomfortable to prepare for. That may be why so many take a pass on it.&n…

https://buff.ly/35HvQcf "By the end of this decade, I predict that these early detection tests will impact cancer survival to a greater extent than therapies."

Council Post: The Precision Medicine Revolution Will Be Driven By Diagnostic Technologies In the future, diagnostic technologies will matter just as much as therapeutics and significantly improve the deployment of healthcare spending.